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Antimicrobial susceptibility of 120 Helicobacter pylori isolates to metronidazole, tetracycline, clarithromycin,
and amoxicillin was determined, and 77.5, 15, 10, and 6.6% of the isolates, respectively, were resistant. Only
rdxA inactivation and both rdxA and frxA inactivation were responsible for metronidazole resistance in 66% (8
of 12) and 33% (4 of 12) of the isolates, respectively.
Eradication of Helicobacter pylori infection by treatment
with two antimicrobial agents (clarithromycin and amoxicillin
or metronidazole) and a proton pump inhibitor is recom-
mended by various consensus groups (10, 16, 20). Antimicro-
bial resistance in H. pylori is a growing problem as it is the most
important factor in determining treatment outcome. The prev-
alence of antimicrobial resistance varies with geographical re-
gions (3, 25). Metronidazole resistance in H. pylori has been
shown to be due to mutation in rdxA; mutation in frxA has also
been shown to be associated with metronidazole resistance (11,
12, 23). In Bangladesh, the prevalences of H. pylori infection
among infants, children, and adults are 61, 84, and 92%, re-
spectively (1, 21, 22); however, information on antimicrobial
susceptibility to commonly used drugs in H. pylori treatment is
lacking. This study was conducted to evaluate (i) the preva-
lence of primary antibiotic resistance to commonly used anti-
microbial agents and (ii) the genetic basis for metronidazole
resistance in H. pylori isolates from Bangladesh.
Consecutive patients attending the Gastroenterology De-
partment of Dhaka Medical College Hospital for upper gas-
trointestinal endoscopy were enrolled during 1999 to 2001. Di-
agnosis of peptic ulcer (PU) and non-ulcer dyspepsia (NUD)
or gastritis was based on endoscopic examination of the stom-
ach and duodenum. Biopsy samples were taken from each
patient for culture.
Bacteria were grown in brain heart infusion agar with 7%
sheep blood and incubated at 37°C in 5% O2, 10% CO2, and
85% N2 for 3 to 6 days. The MICs of amoxicillin, clarithromy-
cin, metronidazole, and tetracycline for the isolates were de-
termined by the agar dilution method as described elsewhere
(18, 19). All tests were repeated twice, and H. pylori 26695 was
used as a control. -Lactamase production was tested by the
chromogenic cephalosporin method (6). The molecular mech-
anism of susceptibility and resistance to metronidazole was
studied in 12 isolates. Metronidazole-susceptible (Mtzs) iso-
lates were further studied (by inactivation of rdxA alone or
rdxA and frxA for conversion into an Mtzr phenotype) by
transformation of Mtzs isolates with plasmids pBS-rdxA-cam
(rdxA::cat) and pBS-frxA-kan (frxA::kan) as described earlier
(11, 12).
A total of 278 consecutive patients between 15 and 78 years
of age were enrolled, and among them, 72.7% (202 patients)
were male and 27.3% (76 patients) were female. Among the
patients, 162 had PU and 116 had NUD and 62.6% (174 of
278) were culture positive for H. pylori. Among the culture-
positive patients, 121 (69.5%) were male and 53 (30.4%) were
female and 112 (64.3%) had PU and 62 (35.6%) had NUD. Of
the 174 isolates, a total of 120 were available for antimicrobial
susceptibility testing and 73.3% (88 of 120) and 26.6% (32 of
120) were from PU and NUD patients, respectively. Among
the isolates, 77.5% (93 of 120), 15% (18 of 120), 10% (12 of
120), and 6.6% (8 of 120) were resistant to metronidazole,
tetracycline, clarithromycin, and amoxicillin, respectively (Ta-
ble 1). The range and distribution of MICs for the isolates are
shown in Fig. 1. All amoxicillin-resistant isolates were -lacta-
mase negative. Antimicrobial susceptibilities of the isolates
collected from patients with PU and NUD and males and
females were compared, and no significant difference (P 
0.05) in antimicrobial resistance was observed among these
groups (Table 1).
Inactivation of only rdxA was sufficient to confer the Mtzr
phenotype in 66% (8 of 12) of isolates, 33% (4 of 12) of isolates
were Mtzs, and inactivation of only frxA had little effect on
Mtzs of all 12 isolates. Subsequent frxA inactivation of all
rdxA-deficient strains increased the MIC of metronidazole
from 16 g/ml to 32 g/ml for the eight strains which became
resistant after only rdxA inactivation, and four strains which
were sensitive after only rdxA inactivation reverted to the Mtzr
phenotype (MIC, 32 g/ml).
Resistance to metronidazole was the most common type of
* Corresponding author. Mailing address: Laboratory Sciences Di-
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resistance, with worldwide rates of 10 to 90% (3, 25). The high
prevalence (77%) of metronidazole resistance in Bangladesh
might be due to frequent use of metronidazole for other in-
testinal and gynecological problems. Previous use of metroni-
dazole has been shown to be associated with H. pylori resis-
tance to this antimicrobial agent (17). Two types of Mtzs H.
pylori were isolated in the present study: type I, requiring only
inactivation of rdxA to become resistant; and type II, requiring
inactivation of both rdxA and frxA to become resistant. Only
frxA inactivation did not have any role in metronidazole resis-
tance, as only subsequent inactivation of frxA in rdxA-inacti-
vated isolates reverted from the Mtzs phenotype to the Mtzr
phenotype and increased the MIC for the Mtzr phenotype.
This is in contrast to the findings of Kwon et al., who inter-
preted that the resistant phenotype can obtained by inactiva-
tion either of frxA or rdxA (13). Thus, resistance to metroni-
dazole in H. pylori is mainly due to mutation in the rdxA gene
and results from de novo mutation in the resident rdxA gene,
rather than lateral transfer of a mutant rdxA gene.
The reported prevalence of primary resistance to clarithro-
mycin ranges between 0 and 15% in most countries (3, 25).
Around 10% of the isolates in the present study were clar-
ithromycin resistant. In Bangladesh, clarithromycin was in-
troduced in the late 1990s, and it has been widely used for
eradication of H. pylori. Previous use of macrolides has been
shown to be associated with H. pylori resistance to clarithro-
mycin (17).
Amoxicillin resistance was not considered important until
recently identified in the United States, Canada, and Italy (7,
8). Amoxicillin is one of the most commonly used antimicro-
bial agents in Bangladesh in recent years. Although 6.6% of
the isolates were resistant, none was positive for -lactamase.
Amoxicillin resistance develops due to structural alterations in
one of the penicillin-binding proteins (4, 5, 9) or changes in
other proteins involved in cell wall synthesis (2, 15, 26), and the
resistant phenotype may be lost due to freezing or storage. All
isolates tested in the present study were frozen at least once,
and the low prevalence of the resistance phenotype may be due
to loss during storage. Primary resistance to tetracycline ranges
between 5 and 59% in Asian countries (14, 24, 27). Around
15% of the isolates in the present study were tetracycline
FIG. 1. Distribution of MICs of clarithromycin (a), tetracycline (b), metronidazole (c), and amoxicillin (d) for 120 H. pylori isolates. The
numbers above the bars represent the numbers of the isolates for which the particular MIC applies.
TABLE 1. Antibiotic susceptibility of 120 H. pylori strains isolated
during 1999 to 2001 from Dhaka, Bangladesh
Antimicrobial
agent











Amoxicillin 8 (6.6) 7 (8.0) 1 (3.1) 4 (4.5) 4 (12.5)
Clarithromycin 12 (10) 8 (9.1) 4 (12.5) 7 (8.0) 5 (15.6)
Metronidazole 93 (77.5) 67 (76.1) 26 (81.2) 68 (77.3) 25 (78.1)
Tetracycline 18 (15) 12 (13.6) 6 (18.7) 14 (16.0) 4 (12.5)
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resistant, which is in agreement with an earlier finding from
this region.
Therefore, it is reasonable to conclude that in our geograph-
ical area, antibiotic resistance is an emerging problem for the
treatment of H. pylori-infected patients. The present study also
demonstrates the need for continuous monitoring of the anti-
microbial susceptibility in H. pylori for determination of opti-
mal treatment regimens.
This study was conducted at the ICDDR, B: Centre for Health and
Population Research with the support of SIDA agreement no 2001-
3970, component 75000255/A/7500260.
ICDDR, B acknowledges with gratitude the commitment of SIDA
to the Centre’s research efforts.
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